New Saturday, April 11 – Sunday, April 12, 2026
Pharmacy Laws and Rules Conference
(12 hrs. CPE)

Sale!

New Saturday, April 11 – Sunday, April 12, 2026
Pharmacy Laws and Rules Conference
(12 hrs. CPE)

Original price was: $250.00.Current price is: $225.00.

ACCREDITATION

iCARE Pharmacy Services, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is an knowledge-based activity. Participants may receive up to 12 hours of CPE credit by attending sessions and successfully completing the continuing pharmacy education (CPE) activity evaluation.

iCARE Pharmacy Services, Inc. is approved by the Florida Board of Pharmacy as a provider of continuing pharmacy education.

DISCLOSURES

Speakers have no relevant conflict of interests nor financial relationships.  All persons in a position to control the content of this activity have declared that no conflict of interest exists for this activity.

TARGET AUDIENCE

Pharmacists and Pharmacy Technicians of all practice backgrounds.

CANCELLATION POLICY
Participants must submit cancellations in writing. Participants will receive a credit for a future CPE program.

ZOOM WEBINAR INFORMATION
Participants may join via any electronic device. Be sure to have downloaded the ZOOM software in advance to avoid any delays. You will be able to see the speakers and their presentations. You will be able to respond to speaker learning assessments via the CHAT Feature and ask questions via the Q&A Feature.

Description

Saturday, April 11, 2026

Pharmacy Legislative Update 2026                                                     

8:00-9:30am, 1.5 CEUs C/G/T
Gallop P. Franklin II, PharmD., BCSCP, Assistant Professor of Pharmacy Practice, Florida A&M University College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health

Upon completion of this activity, pharmacists will be able to: Discuss the recent changes of the 2026 Legislative Session and its effect on the profession of pharmacy; Identify new bills and its impact on pharmacy: 340b, pharmacy administration, compounding, drug price act; Describe the steps pharmacy must complete to maintain compliance with current Florida laws; Provide resources the profession may access to remain up to date with current Florida laws.

UAN: 0675-0000-26-013-L03-P            

Upon completion of this activity, technicians will be able to: Discuss the recent changes of the 2026 Legislative Session and its effect on the profession of pharmacy; Describe the steps pharmacy must complete to maintain compliance with current Florida laws; Provide resources the profession may access to remain up to date with current Florida laws.

UAN: 0675-0000-26-013-L03-T

 


Addressing Moral Conflict to Improve Patient Care with Pharmacy Ethics 

9:30-11:00am, 1.5 CEUs C/G/T

Caitlin A. Schaefer PhD, MHA, CPhT, Dragonfly Health, Billing Consultant
Upon completion of this activity, pharmacists will be able to: Define the 4 ethical principles of beneficence, non-maleficence, autonomy, and justice; Review the Pharmacy Code of Ethics; Describe approaches to ethical decision-making; Apply ethical frameworks to reduce moral conflict.

UAN: 0675-0000-26-014-L03-P   

Upon completion of this activity, technicians will be able to: Define the 4 ethical principles of beneficence, non-maleficence, autonomy, and justice; Review the Pharmacy Code of Ethics; Describe approaches to ethical decision-making; Apply ethical frameworks to reduce moral conflict.

UAN: 0675-0000-26-014-L03-T

 

Florida Board of Pharmacy 2 hours                                                  

11:15-1:15pm, 2 CEUs C/G/T

Chris Bierdlam, Of Counsel, Grossman Roopnarine & Bayó, LLC.
Upon completion of this activity, pharmacists will be able to:  Identify recent changes to the Florida statutes affecting the practice of pharmacy and the rule provisions being amended by the Board of Pharmacy to implement those changes; Explain how these new statutes and rules will impact the everyday practice of pharmacy in Florida including licensure implications, compounding, dispensing, recordkeeping, and patient counseling; Evaluate the implications that these changes will have on the everyday practice life of practicing pharmacists; Describe the updates related to pharmacy technician supervision and the current status of the Board’s proposed expansion of pharmacy technician supervision; Apply current legal requirements to real-world pharmacy scenarios to ensure compliance; Recognize the role of pharmacists in collaborative practice and test and treat settings and how they can enhance public health through policy engagement; Summarize anticipated future legislative trends and their potential impact on pharmacy practice.

UAN: 0675-0000-26-015-L03-P    

Upon completion of this activity, technicians will be able to: Identify recent changes to the Florida statutes affecting the practice of pharmacy; Explain how these new statutes and rules will impact the everyday practice of pharmacy in Florida; Describe the updates related to pharmacy technician supervision and the current status of the Board’s proposed expansion of pharmacy technician supervision; Apply current legal requirements to real-world pharmacy scenarios to ensure compliance.

UAN: 0675-0000-26-015-L03-T

 

Prescription Drug Monitoring Program (PDMP): The Basics, FAQs and More 

1:15-2:15pm, 1 CEU C/G/T

Carl Fritz Hayes, BPharm RPH, Senior Pharmacist, E-FORCSE Florida Prescription Drug Monitoring Program
Upon completion of this activity, pharmacists will be able to: Review E-FORCSE's purpose, background, and content; Review Registration Process and Access; Discuss NARxCare reports and locate support material; Discuss recent and future enhancements.

UAN: 0675-0000-26-016-L03-P

Upon completion of this activity, technicians will be able to: Review E-FORCSE's purpose, background, and content; Review Registration Process and Access; Discuss NARxCare reports and locate support material; Discuss recent and future enhancements.

UAN: 0675-0000-26-016-L03-T

 

Sunday, April 12, 2026

Common Regulatory Pitfalls and How to Get into Compliance          

8:00-9:30am, 1.5 CEUs C/G/T

Michele Weizer, PharmD, BCPS, XRX Solutions, LLC, President and Owner
Upon completion of this activity, pharmacists will be able to: Identify where a PDM finds the rules and regulations governing the practice of pharmacy; Review the role of inspection services and requirements for compliance; Discuss how cases get investigated; progress to a probable cause panel and then to the Board of Pharmacy; Walk through some more frequent redacted board cases and discuss what could have been done by the respondent to prevent the case from progressing.

UAN: 0675-0000-26-017-L03-P

Upon completion of this activity, technicians will be able to: Identify where to find the rules and regulations governing the practice of pharmacy; Review the role of inspection services and requirements for compliance; Discuss how cases get investigated; progress to a probable cause panel and then to the Board of Pharmacy; Walk through some more frequent redacted board cases and discuss what could have been done by the respondent to prevent the case from progressing.

UAN: 0675-0000-26-017-L03-T

 

FSED Oversight and Best Practices                                       

9:30-11:00am, 1.5 CEUs C/G/T

Joel R. McConkey, PharmD, CPh, Pharmacy Supervisor of Off-Site Emergency Departments, Advent Health Central Florida Division
Upon completion of this activity, pharmacists will be able to: Identify Florida Department of Health (DOH) and regulatory requirements​; Prepare FSEDs for DOH inspections​; Ensure readiness for pregnancy-related and pediatric emergencies​; Discuss ASHP antidote guidelines and best practices​; Identify medication gaps and campus support strategies.

UAN: 0675-0000-26-018-L03-P       

Upon completion of this activity, technicians will be able to: Identify Florida Department of Health (DOH) and regulatory requirements​; Prepare FSEDs for DOH inspections​; Ensure readiness for pregnancy-related and pediatric emergencies​; Discuss ASHP antidote guidelines and best practices​; Identify medication gaps and campus support strategies.

UAN: 0675-0000-26-018-L03-T

 

Elevating the Pharmacists Knowledge of Sterile Compounding        

11:15-12:45pm, 1.5 CEUs C/G/T    

Gillain Staikos, RPh, CISCI, Regulatory Compliance Director, Hims and Hers
Upon completion of this activity, pharmacists will be able to: Define terms associated with sterile compounding standards; Discuss the regulatory framework that governs sterile compounding; Develop the knowledge and skills necessary to optimize the quality and safety of Compounded Sterile Preparations.

UAN: 0675-0000-26-019-L07-P     

Upon completion of this activity, technicians will be able to: Define terms associated with sterile compounding standards; Discuss the regulatory framework that governs sterile compounding; Develop the knowledge and skills necessary to optimize the quality and safety of Compounded Sterile Preparations.

UAN: 0675-0000-26-019-L07-T


Florida Pharmacy Disciplinary Process                        

12:45pm-2:15pm, 1.5 CEUs C/G/T

Edwin Bayo, Founding Partner, Grossman, Roopnarine & Bayó, LLC.
Upon completion of this activity, pharmacists will be able to: Describe the life cycle of a Department of Health/Board of Pharmacy investigation from complaint intake through probable cause review, administrative processes, board action, and remedies; Compare the due process rights of pharmacists and permit holders at each stage of the disciplinary process, including notice requirements, access to the investigative file, and available hearing options; Identify the statutory and rule-based grounds for discipline under Chapters 456, 465, 499 & 893, Florida Statutes, and Rule Chapter 64B16, F.A.C., with emphasis on misfills, inspection deficiencies, impairment, and criminal convictions; Formulate proactive compliance strategies—including record-keeping, staff training, and self-reporting—that reduce the risk of disciplinary action and support mitigation if violations occur; Explain the role and obligations of key pharmacy leaders (Prescription Department Manager/PIC and designated representatives) in maintaining permit compliance and responding to DOH inquiries.

UAN: 0675-0000-26-020-L03-P          

Upon completion of this activity, technicians will be able to: Describe the life cycle of a Department of Health/Board of Pharmacy investigation from complaint intake through probable cause review, administrative processes, board action, and remedies; Identify the due process rights at each stage of the disciplinary process; Explain the role and obligations of key pharmacy leaders (Prescription Department Manager/PIC and designated representatives) in maintaining permit compliance and responding to DOH inquiries.

UAN: 0675-0000-26-020-L03-T

***Consultant Pending